Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1261-1270 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|September 14, 2016
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic CellsIlaria Marigo, Serena Zilio, Giacomo Desantis, et al.
Cancer Cell|September 14, 2016
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome ModulationEsther A Obeng, Ryan J Chappell, Michael Seiler, et al.
Cancer Cell|May 10, 2017
Using Epigenetic Reprogramming to Treat Pediatric Brain CancerMilan G Chheda, David H Gutmann
Cancer Cell|May 29, 2018
Biological Role and Therapeutic Potential of IDH Mutations in CancerMatthew S Waitkus, Bill H Diplas, Hai Yan
Cancer Cell|May 29, 2018
Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer CellsBegoña Cánovas, Ana Igea, Alessandro A Sartori, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Cancer Cell|March 16, 2010
The raf inhibitor paradox: unexpected consequences of targeted drugsAdrienne D Cox, Channing J Der
Cancer Cell|March 16, 2010
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4EAndrew C Hsieh, Maria Costa, Ornella Zollo, et al.
Cancer Cell|March 16, 2010
Modulation of the vitamin D3 response by cancer-associated mutant p53Perry Stambolsky, Yuval Tabach, Giulia Fontemaggi, et al.
Cancer Cell|March 16, 2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cellsQing Sheng, Xinggang Liu, Eleanor Fleming, et al.
Pageof 383

Showing results (1261-1270 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|September 14, 2016
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic CellsIlaria Marigo, Serena Zilio, Giacomo Desantis, et al.
Cancer Cell|September 14, 2016
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome ModulationEsther A Obeng, Ryan J Chappell, Michael Seiler, et al.
Cancer Cell|May 10, 2017
Using Epigenetic Reprogramming to Treat Pediatric Brain CancerMilan G Chheda, David H Gutmann
Cancer Cell|May 29, 2018
Biological Role and Therapeutic Potential of IDH Mutations in CancerMatthew S Waitkus, Bill H Diplas, Hai Yan
Cancer Cell|May 29, 2018
Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer CellsBegoña Cánovas, Ana Igea, Alessandro A Sartori, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Cancer Cell|March 16, 2010
The raf inhibitor paradox: unexpected consequences of targeted drugsAdrienne D Cox, Channing J Der
Cancer Cell|March 16, 2010
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4EAndrew C Hsieh, Maria Costa, Ornella Zollo, et al.
Cancer Cell|March 16, 2010
Modulation of the vitamin D3 response by cancer-associated mutant p53Perry Stambolsky, Yuval Tabach, Giulia Fontemaggi, et al.
Cancer Cell|March 16, 2010
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cellsQing Sheng, Xinggang Liu, Eleanor Fleming, et al.
Pageof 383